(2R,3R)-3-[(2S,4S)-4-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3-hydroxy-2-methylpropanoic acid
C13H22FNO5 — CID 122494704
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R,3R)-3-[(2S,4S)-4-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3-hydroxy-2-methylpropanoic acid
(2R,3R)-3-[(2S,4S)-4-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3-hydroxy-2-methylpropanoic acid (PubChem CID 122494704) has the molecular formula C13H22FNO5 and a molecular weight of 291.32 g/mol. Its IUPAC name is (2R,3R)-3-[(2S,4S)-4-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3-hydroxy-2-methylpropanoic acid.
Molecular Properties
| Compound Name | (2R,3R)-3-[(2S,4S)-4-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3-hydroxy-2-methylpropanoic acid |
|---|---|
| PubChem CID | 122494704 |
| Molecular Formula | C13H22FNO5 |
| Molecular Weight | 291.32 g/mol |
| Exact Mass | 291.15 |
| IUPAC Name | (2R,3R)-3-[(2S,4S)-4-fluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidin-2-yl]-3-hydroxy-2-methylpropanoic acid |
| SMILES | C[C@@H](C(=O)O)[C@@H](O)[C@@H]1C[C@H](F)CN1C(=O)OC(C)(C)C |
| InChI | InChI=1S/C13H22FNO5/c1-7(11(17)18)10(16)9-5-8(14)6-15(9)12(19)20-13(2,3)4/h7-10,16H,5-6H2,1-4H3,(H,17,18)/t7-,8+,9+,10-/m1/s1 |
| InChIKey | FVMCGJOWQWIBKU-XFWSIPNHSA-N |
| XLogP | 1.42 |
| TPSA | 87.07 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 291.32 |
| LogP ≤ 5 | 1.42 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122494704 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.